Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionVision Capital Management, Inc.
Latest Disclosed Ownership1,982 shares
Latest Disclosed Value $ 276,177
Vision Capital Management, Inc. reports 2.22% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 24, 2026 - Vision Capital Management, Inc. filed a 13F-HR form disclosing ownership of 1,982 shares of Gilead Sciences, Inc. (CH:GILD) valued at $276,177 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 2,027 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,982 -45 -2.22 276 11.29 0.0218
2026-01-27 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,027 -315 -13.45 249 -4.25 0.0300
2025-10-23 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,342 -3,665 -61.01 260 -61.05 0.0321
2025-07-16 2025-06-30 13F GILEAD SCIENCES COM 375558103 6,007 346 6.11 666 4.89 0.0875
2025-04-30 2025-03-31 13F GILEAD SCIENCES COM 375558103 5,661 -458 -7.48 634 12.21 0.0914
2025-01-27 2024-12-31 13F GILEAD SCIENCES COM 375558103 6,119 -4,789 -43.90 565 -38.18 0.0831
2024-11-05 2024-09-30 13F GILEAD SCIENCES COM 375558103 10,908 8 0.07 915 22.36 0.1289
2024-08-07 2024-06-30 13F GILEAD SCIENCES COM 375558103 10,900 64 0.59 748 -5.80 0.1113
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 10,836 173 1.62 794 -8.11 0.1184
2024-01-17 2023-12-31 13F GILEAD SCIENCES COM 375558103 10,663 -183 -1.69 864 6.28 0.1347
2023-10-25 2023-09-30 13F GILEAD SCIENCES COM 375558103 10,846 -166 -1.51 813 -4.25 0.1496
2023-08-01 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,012 -393 -3.45 849 -10.36 0.1449
2023-05-03 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,405 -400 -3.39 946 -6.61 0.1716
2023-01-26 2022-12-31 13F GILEAD SCIENCES COM 375558103 11,805 -149 -1.25 1,013 37.45 0.1937
2022-10-21 2022-09-30 13F GILEAD SCIENCES COM 375558103 11,954 -3,820 -24.22 737 -24.41 0.1522
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 15,774 -3,051 -16.21 975 -12.87 0.1839
2022-04-28 2022-03-31 13F Gilead Sciences cs 375558103 18,825 1,050 5.91 1,119 -13.32 0.1839
2022-01-24 2021-12-31 13F Gilead Sciences cs 375558103 17,775 54 0.30 1,291 4.28 0.1927
2021-10-07 2021-09-30 13F Gilead Sciences cs 375558103 17,721 421 2.43 1,238 3.95 0.2019
2021-07-15 2021-06-30 13F Gilead Sciences cs 375558103 17,300 3,394 24.41 1,191 32.48 0.1967
2021-04-21 2021-03-31 13F Gilead Sciences cs 375558103 13,906 388 2.87 899 14.09 0.1599
2021-01-20 2020-12-31 13F Gilead Sciences cs 375558103 13,518 7,147 112.18 788 95.53 0.1464
2020-10-21 2020-09-30 13F Gilead Sciences cs 375558103 6,371 77 1.22 403 -16.74 0.0846
2020-07-24 2020-06-30 13F Gilead Sciences cs 375558103 6,294 -2,048 -24.55 484 -22.44 0.1110
2020-04-14 2020-03-31 13F Gilead Sciences cs 375558103 8,342 1,939 30.28 624 50.00 0.1657
2020-01-21 2019-12-31 13F Gilead Sciences cs 375558103 6,403 -438 -6.40 416 -4.15 0.0974
2019-11-01 2019-09-30 13F GILEAD SCIENCES INC COM cs 375558103 6,841 -36,856 -84.34 434 -85.30 0.1127
2019-07-29 2019-06-30 13F GILEAD SCIENCES INC COM cs 375558103 43,697 41 0.09 2,952 4.02 0.7747
2019-05-01 2019-03-31 13F GILEAD SCIENCES INC COM cs 375558103 43,656 3,866 9.72 2,838 14.02 0.7893
2019-01-10 2018-12-31 13F GILEAD SCIENCES INC COM cs 375558103 39,790 -12,285 -23.59 2,489 -38.10 0.7846
2018-10-10 2018-09-30 13F GILEAD SCIENCES INC COM cs 375558103 52,075 223 0.43 4,021 9.47 1.0875
2018-07-06 2018-06-30 13F GILEAD SCIENCES INC COM cs 375558103 51,852 -798 -1.52 3,673 -7.46 1.0698
2018-04-23 2018-03-31 13F GILEAD SCIENCES INC COM cs 375558103 52,650 -2,418 -4.39 3,969 0.61 1.1707
2018-02-08 2017-12-31 13F GILEAD SCIENCES INC COM cs 375558103 55,068 -3,067 -5.28 3,945 -16.24 1.1475
2017-11-09 2017-09-30 13F GILEAD SCIENCES INC COM cs 375558103 58,135 -1,912 -3.18 4,710 10.82 1.4977
2017-08-10 2017-06-30 13F GILEAD SCIENCES INC COM cs 375558103 60,047 -1,449 -2.36 4,250 1.75 1.4577
2017-05-09 2017-03-31 13F GILEAD SCIENCES INC COM cs 375558103 61,496 -1,514 -2.40 4,177 -7.42 1.5009
2017-02-06 2016-12-31 13F GILEAD SCIENCES INC COM cs 375558103 63,010 8,264 15.10 4,512 4.16 1.7625
2016-11-15 2016-09-30 13F GILEAD SCIENCES INC COM cs 375558103 54,746 -1,457 -2.59 4,332 -7.59 1.8152
2016-08-12 2016-06-30 13F GILEAD SCIENCES INC COM cs 375558103 56,203 -67,703 -54.64 4,688 -58.81 1.9855
2016-05-10 2016-03-31 13F GILEAD SCIENCES INC COM cs 375558103 123,906 3,269 2.71 11,382 -6.76 2.7782
2016-02-12 2015-12-31 13F GILEAD SCIENCES INC COM cs 375558103 120,637 -39,321 -24.58 12,207 -22.28 2.7978
2015-11-13 2015-09-30 13F GILEAD SCIENCES INC COM cs 375558103 159,958 7,809 5.13 15,706 -11.83 3.5134
2015-08-14 2015-06-30 13F GILEAD SCIENCES cs 375558103 152,149 -55,662 -26.78 17,814 -12.64 3.3173
2015-05-01 2015-03-31 13F GILEAD SCIENCES cs 375558103 207,811 -71,111 -25.49 20,392 -22.44 3.0521
2015-02-11 2014-12-31 13F GILEAD SCIENCES cs 375558103 278,922 12,197 4.57 26,291 -7.40 3.0274
2014-11-14 2014-09-30 13F GILEAD SCIENCES cs 375558103 266,725 -49,754 -15.72 28,393 8.21 3.5345
2014-08-14 2014-06-30 13F GILEAD SCIENCES cs 375558103 316,479 -34,280 -9.77 26,239 5.57 3.1344
2014-05-15 2014-03-31 13F GILEAD SCIENCES cs 375558103 350,759 12,268 3.62 24,855 -2.23 3.0288
2014-02-18 2013-12-31 13F GILEAD SCIENCES cs 375558103 338,491 -28,617 -7.80 25,421 10.14 3.0244
2013-11-04 2013-09-30 13F GILEAD SCIENCES cs 375558103 367,108 81,632 28.60 23,080 57.69 2.7314
2013-07-25 2013-06-30 13F GILEAD SCIENCES cs 375558103 285,476 285,476 14,636 2.3461
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.